| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $306,868 ) |
| | 2025 | 2025 | CAYMAN CHEMICAL CO INC | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R43DE034602 | Epigenetic Compounds Stimulating Dental Bone Repair | 000 | 1 | NIH | 4/8/2025 | $306,868 |
| | 2025 | 2021 | CAYMAN CHEMICAL CO INC | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 3 | NIH | 11/4/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | CAYMAN CHEMICAL CO INC | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44DE030370 | Novel Small Molecule for Improved Dental Implant Osseointegration | 000 | 2 | NIH | 8/8/2024 | $0 |
| | 2024 | 2020 | CAYMAN CHEMICAL CO INC | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AR076882 | Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton | 000 | 2 | NIH | 10/12/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2021 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 3 | NIH | 6/5/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $906,661 ) |
| | 2022 | 2022 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44DE030370 | Novel Small Molecule for Improved Dental Implant Osseointegration | 001 | 2 | NIH | 8/16/2022 | $906,661 |
| | 2022 | 2021 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44DE030370 | Novel Small Molecule for Improved Dental Implant Osseointegration | 000 | 1 | NIH | 2/7/2022 | $0 |
| | 2022 | 2020 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AR076882 | Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton | 000 | 2 | NIH | 8/26/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,528,304 ) |
| | 2021 | 2021 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 001 | 3 | NIH | 5/17/2021 | $734,479 |
| | 2021 | 2021 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44DE030370 | Novel Small Molecule for Improved Dental Implant Osseointegration | 000 | 1 | NIH | 9/16/2021 | $793,825 |
| | 2021 | 2020 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 2 | NIH | 10/15/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,513,145 ) |
| | 2020 | 2020 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 2 | NIH | 9/17/2020 | $778,104 |
| | 2020 | 2020 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AR076882 | Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton | 000 | 2 | NIH | 8/17/2020 | $750,058 |
| | 2020 | 2017 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R41AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 1 | NIH | 9/15/2020 | -$15,017 |
|
| Issue Date FY: 2019 ( Subtotal = $728,311 ) |
| | 2019 | 2019 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R44AR076882 | Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton | 000 | 1 | NIH | 9/13/2019 | $728,311 |
| | 2019 | 2017 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R41AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 1 | NIH | 10/23/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $224,852 ) |
| | 2017 | 2017 | CAYMAN CHEMICAL COMPANY, INCORPORATED | 1180 E ELLSWORTH RD | ANN ARBOR | MI | 48108-2419 | WASHTENAW | USA | R41AG057274 | Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor | 000 | 1 | NIH | 9/16/2017 | $224,852 |
|
|
